Company
United StatesGalaxy Therapeutics, Inc., Milpitas, CA – FDA Inspections
Inspection records and compliance data for Galaxy Therapeutics, Inc. in Milpitas, CA. 2 FDA inspections on record, 2 Form 483s, last inspected September 01, 2026.
Company Profile
This profile covers Galaxy Therapeutics, Inc. based in Milpitas, CA, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 0
- NAI
- 0
- Unclassified
- 2
- Form 483s
- 2
- Warning letters
- 0
First inspected June 30, 2026. Last inspected September 1, 2026.
Most cited issue areas
- Monitors not qualified1 inspection
- No investigator agreement1 inspection
- Process for production and service provision not validated1 inspection
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| September 1, 2026 | Not classified | Medical Devices & Rad Health · Project Evaluation: Devices | 1333876 |
| June 30, 2026 | Not classified | Medical Devices & Rad Health · Project Evaluation: Devices | 1325552 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Galaxy Therapeutics, Inc.
FEI Number
3022418643
Address
803 Ames Ave, Milpitas, CA 95035-6322, United States
Country
United States
ID: ec313275-97d9-457f-a694-98d1d08eba47